schliessen

Filtern

 

Bibliotheken

The Role of Organizational Affiliations and Research Networks in the Diffusion of Breast Cancer Treatment Innovation

INTRODUCTION:: The National Institutes of Health (NIH) sees provider-based research networks and other organizational linkages between academic researchers and community practitioners as promising vehicles for accelerating the translation of research into practice. This study examines whether organi... Full description

Journal Title: Medical Care 2011, Vol.49(2), pp.172-179
Main Author: Carpenter, R., William
Other Authors: Reeder-Hayes, D., Katherine , Bainbridge, J., John , Meyer, A., Anne-Marie , Amos, A., Keith , Weiner, A., Bryan , Godley, A., Paul
Format: Electronic Article Electronic Article
Language:
Subjects:
ID: ISSN: 0025-7079 ; DOI: 10.1097/MLR.0b013e3182028ff2
Link: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005650-201102000-00010
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: ovid00005650-201102000-00010
title: The Role of Organizational Affiliations and Research Networks in the Diffusion of Breast Cancer Treatment Innovation
format: Article
creator:
  • Carpenter, R., William
  • Reeder-Hayes, D., Katherine
  • Bainbridge, J., John
  • Meyer, A., Anne-Marie
  • Amos, A., Keith
  • Weiner, A., Bryan
  • Godley, A., Paul
subjects:
  • Medicine
  • Public Health
ispartof: Medical Care, 2011, Vol.49(2), pp.172-179
description: INTRODUCTION:: The National Institutes of Health (NIH) sees provider-based research networks and other organizational linkages between academic researchers and community practitioners as promising vehicles for accelerating the translation of research into practice. This study examines whether organizational research affiliations and teaching affiliations are associated with accelerated diffusion of sentinel lymph node biopsy (SLNB), an innovation in the treatment of early-stage breast cancer. METHODS:: Surveillance Epidemiology and End Results-Medicare data were used to examine the diffusion of SLNB for treatment of early-stage breast cancer among women aged 65 years and older diagnosed between 2000 and 2002, shortly after Medicare approved and began reimbursing for the procedure. RESULTS:: In this population, patients treated at an organization affiliated with a research network—-the American College of Surgeons Oncology Group (ACOSOG) or other National Cancer Institute (NCI) cooperative groups—-were more likely to receive the innovative treatment (SLNB) than patients treated at unaffiliated organizations (odds ratio: 2.70, 95% confidence interval: 1.77–4.12; odds ratio: 1.84, 95% confidence interval: 1.26–2.69, respectively). Neither hospital teaching status nor surgical volume was significantly associated with differences in SLNB use. DISCUSSION:: Patients who receive cancer treatment at organizations affiliated with cancer research networks have an enhanced probability of receiving SLNB, an innovative procedure that offers the promise of improved patient outcomes. Study findings support the NIH Roadmap and programs such as the NCIʼs Community Clinical Oncology Program, as they seek to accelerate the translation of research into practice by simultaneously accelerating and broadening cancer research in the community.
language:
source:
identifier: ISSN: 0025-7079 ; DOI: 10.1097/MLR.0b013e3182028ff2
fulltext: fulltext
issn:
  • 0025-7079
  • 00257079
url: Link


@attributes
ID1040390982
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid00005650-201102000-00010
sourceidovid
recordidTN_ovid00005650-201102000-00010
sourceformatXML
sourcesystemOther
pqid843413084
display
typearticle
titleThe Role of Organizational Affiliations and Research Networks in the Diffusion of Breast Cancer Treatment Innovation
creatorCarpenter, R., William ; Reeder-Hayes, D., Katherine ; Bainbridge, J., John ; Meyer, A., Anne-Marie ; Amos, A., Keith ; Weiner, A., Bryan ; Godley, A., Paul
ispartofMedical Care, 2011, Vol.49(2), pp.172-179
identifierISSN: 0025-7079 ; DOI: 10.1097/MLR.0b013e3182028ff2
descriptionINTRODUCTION:: The National Institutes of Health (NIH) sees provider-based research networks and other organizational linkages between academic researchers and community practitioners as promising vehicles for accelerating the translation of research into practice. This study examines whether organizational research affiliations and teaching affiliations are associated with accelerated diffusion of sentinel lymph node biopsy (SLNB), an innovation in the treatment of early-stage breast cancer. METHODS:: Surveillance Epidemiology and End Results-Medicare data were used to examine the diffusion of SLNB for treatment of early-stage breast cancer among women aged 65 years and older diagnosed between 2000 and 2002, shortly after Medicare approved and began reimbursing for the procedure. RESULTS:: In this population, patients treated at an organization affiliated with a research network—-the American College of Surgeons Oncology Group (ACOSOG) or other National Cancer Institute (NCI) cooperative groups—-were more likely to receive the innovative treatment (SLNB) than patients treated at unaffiliated organizations (odds ratio: 2.70, 95% confidence interval: 1.77–4.12; odds ratio: 1.84, 95% confidence interval: 1.26–2.69, respectively). Neither hospital teaching status nor surgical volume was significantly associated with differences in SLNB use. DISCUSSION:: Patients who receive cancer treatment at organizations affiliated with cancer research networks have an enhanced probability of receiving SLNB, an innovative procedure that offers the promise of improved patient outcomes. Study findings support the NIH Roadmap and programs such as the NCIʼs Community Clinical Oncology Program, as they seek to accelerate the translation of research into practice by simultaneously accelerating and broadening cancer research in the community.
source
subjectMedicine ; Public Health;
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005650-201102000-00010$$EView_record_at_Wolters_Kluwer_Health_Ovid_Technologies
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutOvid.html$$EView_Wolters_Kluwer_Health,_Lippincott,_Williams_&_Wilkins_Copyright_Statement
search
creatorcontrib
0Carpenter, R, William
1Reeder-Hayes, D, Katherine
2Bainbridge, J, John
3Meyer, A, Anne-Marie
4Amos, A, Keith
5Weiner, A, Bryan
6Godley, A, Paul
titleThe Role of Organizational Affiliations and Research Networks in the Diffusion of Breast Cancer Treatment Innovation
descriptionINTRODUCTION:: The National Institutes of Health (NIH) sees provider-based research networks and other organizational linkages between academic researchers and community practitioners as promising vehicles for accelerating the translation of research into practice. This study examines whether organizational research affiliations and teaching affiliations are associated with accelerated diffusion of sentinel lymph node biopsy (SLNB), an innovation in the treatment of early-stage breast cancer. METHODS:: Surveillance Epidemiology and End Results-Medicare data were used to examine the diffusion of SLNB for treatment of early-stage breast cancer among women aged 65 years and older diagnosed between 2000 and 2002, shortly after Medicare approved and began reimbursing for the procedure. RESULTS:: In this population, patients treated at an organization affiliated with a research network—-the American College of Surgeons Oncology Group (ACOSOG) or other National Cancer Institute (NCI) cooperative groups—-were more likely to receive the innovative treatment (SLNB) than patients treated at unaffiliated organizations (odds ratio: 2.70, 95% confidence interval: 1.77–4.12; odds ratio: 1.84, 95% confidence interval: 1.26–2.69, respectively). Neither hospital teaching status nor surgical volume was significantly associated with differences in SLNB use. DISCUSSION:: Patients who receive cancer treatment at organizations affiliated with cancer research networks have an enhanced probability of receiving SLNB, an innovative procedure that offers the promise of improved patient outcomes. Study findings support the NIH Roadmap and programs such as the NCIʼs Community Clinical Oncology Program, as they seek to accelerate the translation of research into practice by simultaneously accelerating and broadening cancer research in the community.
general
010.1097/MLR.0b013e3182028ff2
1© 2011 Lippincott Williams & Wilkins, Inc.
2Lippincott Williams & Wilkins - Journals
sourceidovid
recordidovid00005650-201102000-00010
issn
00025-7079
100257079
rsrctypearticle
creationdate2011
addtitleMedical Care
searchscopeovid
scopeovid
lsr30VSR-Enriched:[pqid, eissn, subject]
sort
titleThe Role of Organizational Affiliations and Research Networks in the Diffusion of Breast Cancer Treatment Innovation
authorCarpenter, R., William ; Reeder-Hayes, D., Katherine ; Bainbridge, J., John ; Meyer, A., Anne-Marie ; Amos, A., Keith ; Weiner, A., Bryan ; Godley, A., Paul
creationdate20110200
facets
frbrgroupid5746872869481053067
frbrtype5
creationdate2011
collectionLippincott Williams & Wilkins Journals (Wolters Kluwer Health)
prefilterarticles
rsrctypearticles
creatorcontrib
0Carpenter, R., William
1Reeder-Hayes, D., Katherine
2Bainbridge, J., John
3Meyer, A., Anne-Marie
4Amos, A., Keith
5Weiner, A., Bryan
6Godley, A., Paul
jtitleMedical Care
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Carpenter
1Reeder-Hayes
2Bainbridge
3Meyer
4Amos
5Weiner
6Godley
aufirst
0William
1Katherine
2John
3Anne-Marie
4Keith
5Bryan
6Paul
auinitm
0R.
1D.
2J.
3A.
au
0Carpenter, R., William
1Reeder-Hayes, D., Katherine
2Bainbridge, J., John
3Meyer, A., Anne-Marie
4Amos, A., Keith
5Weiner, A., Bryan
6Godley, A., Paul
atitleThe Role of Organizational Affiliations and Research Networks in the Diffusion of Breast Cancer Treatment Innovation
jtitleMedical Care
risdate201102
volume49
issue2
spage172
epage179
pages172-179
issn0025-7079
formatjournal
genrearticle
ristypeJOUR
abstractINTRODUCTION:: The National Institutes of Health (NIH) sees provider-based research networks and other organizational linkages between academic researchers and community practitioners as promising vehicles for accelerating the translation of research into practice. This study examines whether organizational research affiliations and teaching affiliations are associated with accelerated diffusion of sentinel lymph node biopsy (SLNB), an innovation in the treatment of early-stage breast cancer. METHODS:: Surveillance Epidemiology and End Results-Medicare data were used to examine the diffusion of SLNB for treatment of early-stage breast cancer among women aged 65 years and older diagnosed between 2000 and 2002, shortly after Medicare approved and began reimbursing for the procedure. RESULTS:: In this population, patients treated at an organization affiliated with a research network—-the American College of Surgeons Oncology Group (ACOSOG) or other National Cancer Institute (NCI) cooperative groups—-were more likely to receive the innovative treatment (SLNB) than patients treated at unaffiliated organizations (odds ratio: 2.70, 95% confidence interval: 1.77–4.12; odds ratio: 1.84, 95% confidence interval: 1.26–2.69, respectively). Neither hospital teaching status nor surgical volume was significantly associated with differences in SLNB use. DISCUSSION:: Patients who receive cancer treatment at organizations affiliated with cancer research networks have an enhanced probability of receiving SLNB, an innovative procedure that offers the promise of improved patient outcomes. Study findings support the NIH Roadmap and programs such as the NCIʼs Community Clinical Oncology Program, as they seek to accelerate the translation of research into practice by simultaneously accelerating and broadening cancer research in the community.
pub© 2011 Lippincott Williams & Wilkins, Inc.
doi10.1097/MLR.0b013e3182028ff2
eissn15371948
date2011-02